Drug Trial Radar · NCT07018635
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
Last checked: Nov 19, 2026Latest source record: Nov 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
63
Actual
Start
Jul 16, 2025
Primary completion
Sep 29, 2025
Study completion Sep 29, 2025
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- Jun 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is conducted to assess the effect of itraconazole, rifampin, and acid-reducing agents on INCB161734 pharmacokinetics when administered orally in healthy participants.
Conditions
- Healthy Participants
Interventions
INCB161734Drug
Oral; Tablet
ItraconazoleDrug
Oral; Tablet
RifampinDrug
Oral; Tablet
EsomeprazoleDrug
Oral; Tablet
FamotidineDrug
Oral; Tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics Parameter (PK): Cmax of INCB161734Time frame: Up to 2 months
- Pharmacokinetics Parameter: AUC(0-t) of INCB161734Time frame: Up to 2 months
- Pharmacokinetics Parameter: AUC 0-∞ of INCB161734Time frame: Up to 2 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fortrea Clinical Research Unit Ltd Labcorp Clinical Research Unit Limited Madison
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.